Clinical Trial Update: Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System® [NA]

View source ↗

Summary

This clinical trial update describes a safety and efficacy study of the Xoft Axxent eBx IORT System for invasive ductal carcinoma and ductal carcinoma in situ, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ
• Invasive Ductal Carcinoma

Drugs mentioned

• Xoft Axxent eBx IORT System

Snippet

Sponsor: Xoft, Inc. | Conditions: Invasive Ductal Carcinoma, Ductal Carcinoma in Situ | NA | Status: ACTIVE_NOT_RECRUITING